China Health Group Ltd. Completes Private Placement and Rights Issue, Raising Capital Through New Share Subscriptions

Reuters
Oct 06
<a href="https://laohu8.com/S/CHHE">China Health</a> Group Ltd. Completes Private Placement and Rights Issue, Raising Capital Through New Share Subscriptions

China Health Group Limited has announced the successful completion of a new share subscription under a specific mandate, alongside a rights issue. The rights issue was conducted on the basis of three rights shares for every ten shares held on the record date, at an issue price of HK$0.10 per rights share. Following these transactions, the company's total issued share capital increased to 1,339,138,191 shares. Key shareholders, including Mr. Zhang and Mr. Ying, increased their stakes through direct and indirect holdings. The company stated that the Board is confident in the accuracy of the information provided and has undertaken thorough due diligence regarding this capital raising initiative.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Group Ltd. published the original content used to generate this news brief on October 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10